Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19. Reply
N Engl J Med
.
2021 Sep 16;385(12):1149.
doi: 10.1056/NEJMc2108482.
Epub 2021 Aug 18.
Authors
Ivan O Rosas
1
,
Benjamin Raby
2
,
Larry Tsai
3
Affiliations
1
Baylor College of Medicine, Houston, TX ivan.rosas@bcm.edu.
2
Boston Children's Hospital, Boston, MA.
3
Genentech, South San Francisco, CA.
PMID:
34407336
DOI:
10.1056/NEJMc2108482
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19*
Critical Illness*
Humans
Receptors, Interleukin-6
SARS-CoV-2
Substances
Receptors, Interleukin-6